全文获取类型
收费全文 | 1353737篇 |
免费 | 100956篇 |
国内免费 | 4367篇 |
专业分类
耳鼻咽喉 | 17046篇 |
儿科学 | 43991篇 |
妇产科学 | 36739篇 |
基础医学 | 199997篇 |
口腔科学 | 36627篇 |
临床医学 | 130974篇 |
内科学 | 262626篇 |
皮肤病学 | 26783篇 |
神经病学 | 113441篇 |
特种医学 | 48615篇 |
外国民族医学 | 366篇 |
外科学 | 186973篇 |
综合类 | 28894篇 |
现状与发展 | 1篇 |
一般理论 | 467篇 |
预防医学 | 115494篇 |
眼科学 | 29524篇 |
药学 | 99810篇 |
7篇 | |
中国医学 | 3212篇 |
肿瘤学 | 77473篇 |
出版年
2021年 | 11507篇 |
2019年 | 12187篇 |
2018年 | 16988篇 |
2017年 | 12670篇 |
2016年 | 13690篇 |
2015年 | 15746篇 |
2014年 | 21552篇 |
2013年 | 32984篇 |
2012年 | 45766篇 |
2011年 | 48432篇 |
2010年 | 27905篇 |
2009年 | 25683篇 |
2008年 | 43921篇 |
2007年 | 46344篇 |
2006年 | 46313篇 |
2005年 | 44621篇 |
2004年 | 42443篇 |
2003年 | 40243篇 |
2002年 | 39007篇 |
2001年 | 60971篇 |
2000年 | 62615篇 |
1999年 | 52414篇 |
1998年 | 14720篇 |
1997年 | 13395篇 |
1996年 | 13207篇 |
1995年 | 12575篇 |
1994年 | 11733篇 |
1993年 | 11026篇 |
1992年 | 41655篇 |
1991年 | 40836篇 |
1990年 | 39512篇 |
1989年 | 37387篇 |
1988年 | 34629篇 |
1987年 | 33733篇 |
1986年 | 32196篇 |
1985年 | 30674篇 |
1984年 | 23092篇 |
1983年 | 19638篇 |
1982年 | 11804篇 |
1979年 | 20833篇 |
1978年 | 14846篇 |
1977年 | 12089篇 |
1976年 | 11904篇 |
1975年 | 12131篇 |
1974年 | 14823篇 |
1973年 | 14499篇 |
1972年 | 13370篇 |
1971年 | 12436篇 |
1970年 | 11501篇 |
1969年 | 10420篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Vasundhara Sridharan Yuichi Shoda Jaimee L. Heffner Jonathan Bricker 《Substance use & misuse》2019,54(7):1086-1095
Background: Lay belief systems about the malleability of human attributes have been shown to impact behavior change in multiple domains. Addiction mindset—i.e., beliefs about the permanence (vs. malleability) of addiction — may affect cigarette smokers’ ability to quit, but this has never been examined. Objectives: The aims of the present research were to develop a measure of addiction mindset (study 1) and examine its associations with various psychological aspects of quitting smoking (study 2). Methods: In Study 1, using factor analysis of current smokers’ and nonsmokers’ (n?=?600) responses to 22 items designed to measure addiction mindset, we developed a reliable six-item Addiction Mindset Scale (AMS). In Study 2, adult smokers (n?=?200) completed the AMS, and measures of a number of psychological processes related to smoking. Results: Higher scores on the AMS, indicative of the belief that addiction is malleable (referred to as a growth mindset), were positively and significantly associated with greater motivation to quit, greater commitment to quitting, greater self-efficacy to abstain, less attribution of failure to lack of ability to change addiction, and fewer self-reported barriers to cessation (all p’s < .05). Conclusions: The results of this study show a relationship between the beliefs about the permanence of addiction and psychological processes relevant to quitting smoking. The findings underscore the potential of future research exploring how addiction mindsets relate to successful smoking cessation as well as other types of addictive behavior and how they can be applied to change people’s behavior. 相似文献
3.
Stepanova E. S. Makarenkova L. M. Chistyakov V. V. Rybakov Yu. L. Gukasov V. M. Fedotcheva T. A. Parshin V. A. Votyakov V. A. Shimanovskii N. L. 《Pharmaceutical Chemistry Journal》2019,52(12):1016-1020
Pharmaceutical Chemistry Journal - An HPLC-MS method for simultaneous quantitative determination of a novel gestagenic pharmaceutical and two of its metabolites in rat and rabbit blood sera was... 相似文献
4.
5.
6.
7.
8.
9.
10.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献